Research
UBC research pinpoints how early-life antibiotics turn immunity into allergy
August 21, 2024
Researchers from UBC have shown for the first time how and why the depletion of microbes in a newborn’s gut by antibiotics can lead to lifelong respiratory allergies.
Transforming Transfusion: engineered platelets using lipid nanoparticles
July 9, 2024
A new exciting avenue of transfusion research is being investigated by the Kastrup, Cullis, Jan, and Devine labs at the CBR. They delve into the possibility of genetically modifying platelets to express proteins that may offer greater therapeutic benefits.
Antibiotic Failure – Beyond Antimicrobial Resistance
July 2, 2024
A recent review by the Hancock Lab delves into antimicrobial resistance, with topics that include contributors to antibiotic failure, how these may be alleviated by rapid diagnostics, and alternatives to antibiotics.
Jefferies lab demonstrates potential of a novel cell-based immunotherapy for cancer
May 8, 2024
A new study from the Jefferies lab highlights a promising, novel avenue for cancer immunotherapy using Type 2 innate lymphoid cells.
Familial Alzheimer’s disease transferred via bone marrow transplant in mice
April 10, 2024
In a recent study, Dr. Wilfred Jefferies & Dr. Chaahat Singh show that familial Alzheimer’s disease can be transferred via bone marrow transplant.
Targeting a hitherto enigmatic protein could help to treat people with insulin resistance
April 9, 2024
A new study highlights the CD248 protein as potentially being key in combatting insulin resistance, a core problem in type 2 diabetes.
Modifying Material Surfaces for Biomedical Applications
March 20, 2024
In this piece, Erik Lamoureux introduces the unique challenges associated with biomaterial surface modifications in a biomedical setting, and a recent publication on studies by the Kizhakkedathu group.
Research That Makes You Want to Smile: Novel Role for Granzyme B in Periodontal Inflammation
February 28, 2024
Researchers in the Kim lab have discovered a new role for serine protease Granzyme B (GzmB).
The Discovery of New Sentinels on the Immune Watchtower for Cancer
February 20, 2024
In the latest study by the Jefferies lab, we delve into the intricate world of type-2 innate lymphoid cells (ILC2), specifically exploring their plasticity during tumour expansion .
Hotwire the Cure: Turning Cold Tumors Hot
January 29, 2024
Research by Dr. Julyanne Brassard, recently published in Frontiers in Oncology, highlights a promising new therapeutic target for ovarian cancer.